Caregivers' and physicians' attitudes to rotigotine transdermal patch versus oral Parkinson's disease medication: an observational study

Current Medical Research and Opinion
Jörn Peter SiebStefan Lorenzl

Abstract

To provide real-world data on caregiver and physician perceptions of the advantages and disadvantages of rotigotine transdermal patch (Neupro * ) versus oral Parkinson's Disease (PD) medication. Cross-sectional, non-interventional study in routine clinical practice in Germany (NCT01330290). Patients had PD with documented need for care, and had received rotigotine transdermal patch as add-on to oral PD treatment for ≥1 month. Caregivers/nurses and physicians assessed rotigotine transdermal patch versus oral PD medications using questionnaires. Specific questions regarding the possible benefits of transdermal application were asked and comprised questions on: swallowing dysfunction, nausea/vomiting, monitoring therapy, once daily application, application independently from meals, application to sleeping patients, caregiving efforts (caregivers only) and clinical aspects (physicians only). Each question was assessed on a 5 point scale ranging from -2 (major disadvantage) to 2 (major advantage) compared with oral treatment. Primary outcomes were mean total scores of all questions for caregivers/nurses and physicians who provided responses for ≥4 questions. As there are no validated tools to assess physician/caregiver preference in...Continue Reading

References

Sep 1, 2000·Journal of the American Geriatrics Society·D AarslandK Laake
May 11, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Norman A LeopoldMarcia R Hurka
Dec 21, 2006·Journal of Neural Transmission·A D KorczynH-J Häck
Jan 24, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Pablo Martínez-MartínMaría José Catalán
Feb 20, 2007·Clinical Drug Investigation·Matthias FargelMarkus Rupp
Apr 5, 2007·International Journal of Geriatric Psychiatry·Bengt WinbladRafael Blesa
Apr 18, 2007·Neurology·Peter A LeWittUNKNOWN SP 650 Study Group
May 16, 2007·Archives of Neurology·Joseph JankovicBabak Boroojerdi
Oct 16, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Nir GiladiUNKNOWN SP513 investigators
Nov 11, 2008·Journal of the American Medical Directors Association·Winona TseLeslie S Libow
Feb 5, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Donald GrossetKatherine Grosset
Oct 2, 2009·Journal of the Neurological Sciences·Donald Grosset, UNKNOWN European PD Therapy Compliance Study Group
Jun 11, 2010·Journal of Neural Transmission·Ullrich WüllnerUNKNOWN NEUPOS Study Group
Jul 8, 2010·Parkinsonism & Related Disorders·Alfons SchnitzlerHermann-Josef Häck
Jan 26, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Pablo Martinez-MartinUNKNOWN NMSS Validation Group
Feb 16, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Claudia TrenkwalderUNKNOWN Recover Study Group
Jun 29, 2011·British Journal of Clinical Pharmacology·Willi CawelloMarina Braun
Jul 12, 2011·Parkinsonism & Related Disorders·K Ray ChaudhuriPablo Martinez-Martin
Mar 31, 2012·Expert Review of Pharmacoeconomics & Outcomes Research·Pablo Martinez-MartinMaria João Forjaz
Jun 13, 2012·Current Medical Research and Opinion·Ullrich WüllnerJan Kassubek
Jul 6, 2014·Journal of the American Medical Directors Association·Anouke van RumundBastiaan R Bloem

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.